CYTOMOS
Cytomos® develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma and cell therapy domains. Built upon our patented Cytomos® Dielectric Spectroscopy (CDS™) technology, our systems are unbiased, have single-cell resolution and are scalable across all upstream production stages. Leveraging the unmatched data depth per cell provided by CDS™, our proprietary machine learning (ML) algorithms provide insights into your bioprocesses like never before.
CYTOMOS
Industry:
Biopharma Biotechnology Machine Learning Medical
Founded:
2011-01-01
Address:
Edinburgh, Edinburgh, City Of, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cytomos.com
Total Employee:
1+
Status:
Active
Contact:
+44 131 272 2770
Email Addresses:
[email protected]
Total Funding:
1.7 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Current Employees Featured
Founder
Investors List
Archangels
Archangels investment in Seed Round - Cytomos
Scottish Enterprise
Scottish Enterprise investment in Seed Round - Cytomos
Old College Capital
Old College Capital investment in Seed Round - Cytomos
Archangels
Archangels investment in Seed Round - Cytomos
Official Site Inspections
http://www.cytomos.com
- Host name: server9.lilacsoftware.co.uk
- IP address: 62.100.206.54
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Cytomos"
About Us - Cytomos
Cytomos is a purpose and impact driven organisation that is successfully repurposing microelectronics to enable the cost-effective use of biotechnologies and allow economies of scale. AuraCytâ„¢ was developed by an in-house …See details»
Cytomos - Crunchbase Company Profile & Funding
Cytomos may be growing as it has secured 4 million in funding to advance its operations, indicating a strong financial backing and confidence from investors. The company is also targeting commercialization of its platforms in 2024, …See details»
Cytomos Company Profile 2024: Valuation, Funding
Cytomos General Information Description. Developer of a dielectric spectroscopy technology designed to assist with label-free cell analysis for biomedical research. The company's patented cell analysis technology ensures that every cell is …See details»
Cytomos Overview | SignalHire Company Profile
Oct 3, 2022 Built upon our patented Cytomos® Dielectric Spectroscopy (C... Cytomos® develops and provides integrated, predictive analytics systems for intelligent bioprocessing in …See details»
Cytomos Company Profile - Office Locations, Competitors ... - Craft
Cytomos has 5 employees at their 1 location and $165.19 k in total funding,. See insights on Cytomos including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Cytomos Limited - Edinburgh, United Kingdom - bionity.com
Aug 9, 2023 Cytomos secures £4M to advance new approach to cell analysis. Cytomos, an Edinburgh-based life science company that has developed a proprietary new approach to …See details»
Cytomos - Products, Competitors, Financials, Employees, …
About Cytomos. Cytomos is a biotech company focused on revolutionizing cell analysis through its proprietary technology. Its main offering includes single-cell analytics and detection of …See details»
Cytomos Limited - Pioneer Group
Cytomos is the first TechBio company finally enabling game-changing decisions through its patented real-time AuraCytâ„¢ platform agnostically translating complex cell data into …See details»
Cytomos - Funding, Financials, Valuation & Investors - Crunchbase
Cytomos develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma. Search Crunchbase. Start Free Trial . ... How much funding has …See details»
Cytomos raises £5m to advance scalable cell-analysis tech for drug ...
Nov 19, 2024 Cytomos, an Edinburgh-based biotech, has secured £5 million in funding to scale up production of its innovative cell-analysis platform, AuraCyt, and its first commercial product, …See details»
Startup Cytomos secures £4m of new investment
Jul 11, 2023 The Company has developed its Cytomos Dielectric Spectroscopy (CDS) platform to meet unmet requirements of the biopharma industry. The CDS platform will provide high …See details»
Cytomos - Overview, News & Similar companies | ZoomInfo.com
Aug 7, 2023 Cytomos secures £1.6m additional seed funding led by Archangels Cytomos secures £1.6m additional seed funding led by Archangels Submitted 28/06/2022 - 9:28am …See details»
Cytomos - Contacts, Employees, Board Members, Advisors & Alumni
Cytomos develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma.See details»
News | Roslin Innovation Centre
Cytomos has developed CDS to address the unmet needs of the biopharma industry, providing a groundbreaking high-speed, scalable and low-cost revolution beyond current cell analysis …See details»
Cytomos raises £5M to scale up cell-analysis production
Nov 19, 2024 Cytomos' technology AuraCyt is an unbiased, scalable cell analysis platform to provide a scalable alternative to current cell analysis systems. Using this platform, Cytomos …See details»
article - Cytomos
Cytomos' unique technology AuraCyt is an unbiased, scalable cell analysis platform which addresses this unmet need, providing a groundbreaking low-cost, and scalable alternative to …See details»
Cytomos raises $5m to scale up cell analysis technology production
Nov 21, 2024 Cytomos has announced that it has raised $5m in an oversubscribed funding round to scale up production of its cell analysis technology. The Edinburgh-based biotech said …See details»
Cytomos Seeks to Accelerate Advanced Therapy Manufacturing
Dec 12, 2023 Cytomos is set to offer products and services to early adopters by the second quarter of 2024. This will include supporting the setup of the instrument, cell screening, and …See details»
News - Cytomos
Cytomos showcases groundbreaking new platform for advanced cell analytics at ISCT 2024 22 May 2024 At this year’s annual meeting of the International Society for Cell & Gene Therapy …See details»